Caladrius Biosciences Inc

NASDAQ:CLBS   3:57:24 PM EDT
0.48
+0.02 (+4.61%)
Earnings Announcements

Caladrius Biosciences Reports Fourth Quarter And Full Year 2021 Results

Published: 03/22/2022 20:29 GMT
Caladrius Biosciences Inc (CLBS) - Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.